&nbsp;

Thymic-Cancer-Pathway-Map-Acknowledgments.pdf

Dec 1969

Document

Thymic-Diagnosis-Pathway.pdf

Dec 1969

Document

Thymic-Follow-Up-Pathway.pdf

Dec 1969

Document

Thymic-Treatment-Pathway.pdf

Dec 1969

Thymic Cancer Pathway Map

Guidelines and Advice

The Use of Indoor Tanning Devices and the Risk of Developing Cutaneous Malignant Melanoma: A Systematic Review and Clinical Practice Guideline

Status: In-Review
ID: 8-8

Dec 1969

Non-Hodgkin Lymphoma

Regimen

TRBC(MNT)

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Palliative

Drugs Used:

trabectedin (Unfunded)

Quick Link(s):

Regimen Monograph

Regimen

NIVL+IPIL

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Drugs Used:

nivolumab (Unfunded),

ipilimumab (Unfunded)

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Nov 2024

Regimen

NIVL+IPIL

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - Metastatic Renal Cell Carcinoma

New Drug Funding Program

Nivolumab plus Ipilimumab - Metastatic Renal Cell Carcinoma

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Nov 2024

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Drugs Used:

nivolumab (Unfunded),

ipilimumab (Unfunded)